Lead Product(s): Trifarotene
Therapeutic Area: Dermatology
Highest Development Status: Approved Product Type: Small molecule
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership January 08, 2020
Certara's Simcyp population-based Simulator was used to support Galdermaâ€™s successful U.S. FDA new drug application for AKLIEF (trifarotene) Cream, 0.005% for the topical treatment of acne.